Antimicrobial Agents and Chemotherapy Vol. 54 Issue 11

The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins
Hsun-Cheng Su, Kevin Ramkissoon, Janet Doolittle, Martha Clark, Jainab Khatun, Ashley Secrest, Matthew C. Wolfgang, and Morgan C. Giddings

A Chimeric Protein That Functions as both an Anthrax Dual-Target Antitoxin and a Trivalent Vaccine
Gaobing Wu, Yuzhi Hong, Aizhen Guo, Chunfang Feng, Sha Cao, Cheng-Cai Zhang, Ruiping Shi, Yadi Tan, and Ziduo Liu

Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model
Julien Poissy, Alexandra Aubry, Christine Fernandez, Marie-Catherine Lott, Aurelie Chauffour, Vincent Jarlier, Robert Farinotti, and Nicolas Veziris

Synthesis and Spectrum of the Neoglycoside ACHN-490
James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum, Paola Dozzo, Martin S. Linsell, Micah J. Gliedt, Darin J. Hildebrandt, Lee Ann Feeney, Aya Kubo, Rowena D. Matias, Sara Lopez, Marcela Gomez, Kenneth B. Wlasichuk, Raymond Diokno, George H. Miller, and Heinz E. Moser

Discovery and Analysis of 4H-Pyridopyrimidines, a Class of Selective Bacterial Protein Synthesis Inhibitors
Wendy Ribble, Walter E. Hill, Urs A. Ochsner, Thale C. Jarvis, Joseph W. Guiles, Nebojsa Janjic, and James M. Bullard